New treatment could be instrumental in restoring the blood-brain barrier’s normal function

FHS
June 20, 2023
4:51 pm

There’s a bouncer in everyone: The blood-brain barrier, a layer of cells between blood vessels and the rest of the brain, kicks out toxins, pathogens and other undesirables that can sabotage the brain’s precious gray matter.

Understanding the age gap in leukemia survival rates

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to

August 7, 2024

Profiting from ‘legal’ insider trading isn’t always easy

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday

April 25, 2024

Wegovy Cuts Major Heart Risk; Rising Healthcare Violence; Carcinogen at Missile Base

Note that some links may require registration or subscription. Novo Nordisk said its obesity drug semaglutide (Wegovy) cut the risk of a major cardiovascular event

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.